Our Speakers

Dr. Tay is Director of Urologic Oncology and Senior Consultant Urologist at the Singapore General Hospital, and Associate Professor at the Duke-NUS Graduate Medical School. He underwent urology residency at the Singapore General Hospital and the Society of Urologic Oncology (SUO) fellowship at Duke University, North Carolina, USA. His clinical practice includes focal therapy for prostate cancer, robotic pelvic surgery, complex resections of genitourinary (GU) cancers in the pelvis and retroperitoneum, and metastatic prostate cancer.

Dr. Tay has published extensively in the field of urologic oncology with more than 100 publications and book chapters to date. He is the Principal Investigator of a Phase II trial of Focal Cryotherapy for Prostate Cancer. He has received multiple national grants including a Transition Award in 2021, and Clinician Scientist Award in 2025 from the National Medical Research Council, Singapore for his work in risk stratification, advanced imaging, biopsy, active surveillance, and focal therapy of prostate cancer.

Dr. Tay is also currently Secretary for the international Focal Therapy Society He is also ex-Chairman of its Website and Social Media Committee. He organizes Tumor Boards in Focal Therapy – a regular online educational forum for expert sharing of tips, tricks and challenges in Focal Therapy. He aims to develop better risk stratification methods for localized and metastatic prostate cancer and a modern approach to precision medicine in prostate cancer.

Assoc Prof Tay Kae Jack's Session:

• Surgical Symposium 2
  Date: 19 Sep 2025, Friday | Time: 1310—1450 | Venue: Level 2, L2-S2